New SUPER MICROSCOPE Now Available at ShareLab! 🔬
We are excited to welcome Chip NanoImaging and their flagship microscope, ACP ZERO, to the ShareLab community 👏 This innovative startup has developed cutting-edge imaging technology that offers the largest field of view on the market. The ACP ZERO provides crisp TIRF imaging, enabling super-resolution across exceptionally large areas-ideal for applications ranging from membrane dynamics to histological sections 💪
Come see the ACP ZERO in action! Contact Chip NanoImaging AS for a demo and experience the remarkable clarity it delivers 😊
Flore Kersten, Lab Lead at ShareLab, is thrilled about both the new super-microscope and the new startup joining our community:
“We can’t wait to see how these advanced imaging capabilities will enhance our work! Having this unique new tool deployed first at ShareLab is truly an amazing opportunity,” she says. “We look forward to collaborating with the Chip NanoImaging team!” 😀
#chipnano #microscopy #TIRF #SuperResolution #SRM #cellmigration #membrane #nanoscopy
Jan 17
New SUPER MICROSCOPE Now Available at ShareLab! 🔬
We are excited to welcome Chip NanoImaging and their flagship microscope, ACP ZERO, to the ShareLab community 👏 This innovative startup has developed cutting-edge imaging technology that offers the largest field of view on the market. The ACP ZERO provides crisp TIRF imaging, enabling super-resolution across exceptionally large areas-ideal for applications ranging from membrane dynamics to histological sections 💪
Come see the ACP ZERO in action! Contact Chip NanoImaging AS for a demo and experience the remarkable clarity it delivers 😊
Flore Kersten, Lab Lead at ShareLab, is thrilled about both the new super-microscope and the new startup joining our community:
“We can’t wait to see how these advanced imaging capabilities will enhance our work! Having this unique new tool deployed first at ShareLab is truly an amazing opportunity,” she says. “We look forward to collaborating with the Chip NanoImaging team!” 😀
#chipnano #microscopy #TIRF #SuperResolution #SRM #cellmigration #membrane #nanoscopy
🚀 ShareLab is back on Instagram! 🚀
Got a big idea but a small budget to pursue it?💡🤑
ShareLab is here to power up your biotech journey. Whether you’re an academic, entrepreneur, start-up, or industry innovator, we provide the perfect environment to bring your ideas to life. With a state-of-the-art lab, a vibrant network, and tailored mentorship, you can focus on what truly matters: your project 🤝🥼
Follow us for updates on our growing community, success stories, and tips for biotech innovation in Scandinavia. Let’s build the future of biotech together! 🔬💼
#sharelab #sharelabscandinavia #biotechincubator #innovationhub #lablife #entrepreneurship #startup #mentor
Nov 13
🚀 ShareLab is back on Instagram! 🚀
Got a big idea but a small budget to pursue it?💡🤑
ShareLab is here to power up your biotech journey. Whether you’re an academic, entrepreneur, start-up, or industry innovator, we provide the perfect environment to bring your ideas to life. With a state-of-the-art lab, a vibrant network, and tailored mentorship, you can focus on what truly matters: your project 🤝🥼
Follow us for updates on our growing community, success stories, and tips for biotech innovation in Scandinavia. Let’s build the future of biotech together! 🔬💼
#sharelab #sharelabscandinavia #biotechincubator #innovationhub #lablife #entrepreneurship #startup #mentor
Scientists derive satisfaction from figuring out the puzzle. It’s purportedly about the quest, not the grail. Well, for the scientists at ImmunoQuest, it is both.
This week, Esmaeil Dorraji joined ShareLab with his cancer startup, ImmunoQuest Therapeutics. The company is co-founded with oncologist Jon Amund Kyte and the tech transfer office Inven2. The biologic is termed NAZ-001, the target p95Her2, the modality ADC, and the initial indication Her2-positive breast cancer.
Says Esmaeil, “NAZ-001 incorporates clinically validated components to provide a breakthrough therapeutic option for patients with HER2-positive metastatic breast cancer who have become resistant to existing treatments.”
We are all in for the grail.
Okt 4
Scientists derive satisfaction from figuring out the puzzle. It’s purportedly about the quest, not the grail. Well, for the scientists at ImmunoQuest, it is both.
This week, Esmaeil Dorraji joined ShareLab with his cancer startup, ImmunoQuest Therapeutics. The company is co-founded with oncologist Jon Amund Kyte and the tech transfer office Inven2. The biologic is termed NAZ-001, the target p95Her2, the modality ADC, and the initial indication Her2-positive breast cancer.
Says Esmaeil, “NAZ-001 incorporates clinically validated components to provide a breakthrough therapeutic option for patients with HER2-positive metastatic breast cancer who have become resistant to existing treatments.”
We are all in for the grail.
Introducing the latest addition to our lab arsenal: the dPCR equipment from Quiagen.🧬 Sharelab members had such an enlightening day with QIAGEN and received comprehensive training on the new dPCR system. #sharelab #qiagen #forskningsparken #dpcr #oslo
Apr 18
Introducing the latest addition to our lab arsenal: the dPCR equipment from Quiagen.🧬 Sharelab members had such an enlightening day with QIAGEN and received comprehensive training on the new dPCR system. #sharelab #qiagen #forskningsparken #dpcr #oslo
What? A startup already with a product wrapped in plastic? Enzyferm works with special yeast strains for home brewers and are now also aiming at industrial ethanol production with their high yield strains. Cheers!
Core team consists of Leif Chr Hanstad, Øystein Bakken Vold, and Siavash Seif.
Apr 17
What? A startup already with a product wrapped in plastic? Enzyferm works with special yeast strains for home brewers and are now also aiming at industrial ethanol production with their high yield strains. Cheers!
Core team consists of Leif Chr Hanstad, Øystein Bakken Vold, and Siavash Seif.
The Huey, Dewey, and Louie of Norwegian Biotech: Erik, Tor Espen, and Sigurd, founders who of Node Pharma at their new offices at ShareLab. 🤩
#sharelab #biotech #oslo @forskningsparken
Apr 9
The Huey, Dewey, and Louie of Norwegian Biotech: Erik, Tor Espen, and Sigurd, founders who of Node Pharma at their new offices at ShareLab. 🤩
#sharelab #biotech #oslo @forskningsparken
Today Caedo Oncology 💊 and Enzymferm 🍻from Sharelab had the opportunity to showcase their company and goals at the ForkingSparken’s First Friday Pitch event and They delivered a stellar presentations. 👏🏽 also check out Forskningsparken Community Fund for fun activities #forskningsparken #oslo
Mar 1
Today Caedo Oncology 💊 and Enzymferm 🍻from Sharelab had the opportunity to showcase their company and goals at the ForkingSparken’s First Friday Pitch event and They delivered a stellar presentations. 👏🏽 also check out Forskningsparken Community Fund for fun activities #forskningsparken #oslo
Join us for exclusive seminars host by thermo fisher scientific and Sharelab.💡 Discover cutting-edge solutions,streamline your workflows and meet industry experts. Don’t miss out. See you on march 5th. 🗓️ #sharelab #thermofisher #seminar#innovation
Feb 16
Join us for exclusive seminars host by thermo fisher scientific and Sharelab.💡 Discover cutting-edge solutions,streamline your workflows and meet industry experts. Don’t miss out. See you on march 5th. 🗓️ #sharelab #thermofisher #seminar#innovation
Merry Christmas from the team at ShareLab! Remember Christmas is for SHARING! Thanks to all our members and friends for making 2023 another great year at ShareLab 🙏 We wish you all the best for 2024! ❤️ #fpchristmaschallenge
Des 13
Merry Christmas from the team at ShareLab! Remember Christmas is for SHARING! Thanks to all our members and friends for making 2023 another great year at ShareLab 🙏 We wish you all the best for 2024! ❤️ #fpchristmaschallenge
What a great bunch from the School of Health Innovation! The initiative is financed by Novo Nordisk Foundation and is a collaboration between University of Copenhagen (Københavns Universitet), Universitetet i Oslo, Karolinska Institutet, and Norwegian University of Science and Technology (NTNU).
A big part of doing biotech is creating reason to believe that the product will work in the patients, without pouring piles of cash into the project. It is all data, data, data. In fact, data is what most bioentrepreneurs will ever sell. That`s why ShareLab took them to the core of our activity - the lab where it all happens.
#oslo #biotech #sharelab #forskningsparken #healthinnovation
Nov 29
What a great bunch from the School of Health Innovation! The initiative is financed by Novo Nordisk Foundation and is a collaboration between University of Copenhagen (Københavns Universitet), Universitetet i Oslo, Karolinska Institutet, and Norwegian University of Science and Technology (NTNU).
A big part of doing biotech is creating reason to believe that the product will work in the patients, without pouring piles of cash into the project. It is all data, data, data. In fact, data is what most bioentrepreneurs will ever sell. That`s why ShareLab took them to the core of our activity - the lab where it all happens.
#oslo #biotech #sharelab #forskningsparken #healthinnovation
ShareLab team exploring the vibrant world of bioinnovation at the BioInnovation Institute in Copenhagen.🌱💡 Sharing insights on cultivating an exceptional lab culture to foster creativity for bioentrepreneurs. 🥼
Nov 17
ShareLab team exploring the vibrant world of bioinnovation at the BioInnovation Institute in Copenhagen.🌱💡 Sharing insights on cultivating an exceptional lab culture to foster creativity for bioentrepreneurs. 🥼
Biotech novice Sylvester Stallone says "I take rejection as someone blowing a bugle (🎺) in my ear to wake me up and get going, rather than retreat." Georg agrees.
.
.
#sharelab #biotech #abbvie #oslo #entrepreneurship
Sep 27
Biotech novice Sylvester Stallone says "I take rejection as someone blowing a bugle (🎺) in my ear to wake me up and get going, rather than retreat." Georg agrees.
.
.
#sharelab #biotech #abbvie #oslo #entrepreneurship
Therapeutics is a key interest at ShareLab and biologics have so far been the preferred mode. We have, however, more than 20 early stage small molecule projects in holding pattern waiting to land. The waiting is over. Enter Johan Evenäs and RED GLEAD DISCOVERY (RGD). RGD are now members of ShareLab and they will monthly travel from Lund (Sweden) to Oslo to assist projects.
Jun 2
Therapeutics is a key interest at ShareLab and biologics have so far been the preferred mode. We have, however, more than 20 early stage small molecule projects in holding pattern waiting to land. The waiting is over. Enter Johan Evenäs and RED GLEAD DISCOVERY (RGD). RGD are now members of ShareLab and they will monthly travel from Lund (Sweden) to Oslo to assist projects.
"The future`s so bright (I gotta wear shades)"
Professor of medical innovation, antibody expert, Authera cofounder, and ShareLab patron Jan Terje Andersen is the Innovator of the Year 2023 🔥🎉🥳
Mai 31
"The future`s so bright (I gotta wear shades)"
Professor of medical innovation, antibody expert, Authera cofounder, and ShareLab patron Jan Terje Andersen is the Innovator of the Year 2023 🔥🎉🥳
Posts Navigation
Esben A. Nilssen
Managing Partner
Esben has two goals. Make biotech soar and do backcountry skiing until feet sore. A human Swiss knife, Esben started out with philosophy, did a PhD on cell cycle checkpoints, became lover of risk-adjusted NPVs, accidental European Patent Attorney, and finally a bioentrepreneur for more than a decade. He is probably the right man to take you through the jungle (or the polar ice, for that sake).
Connect via ShareLab's Facebook or Instagram profiles, or Esben's LinkedIn.
Marius Øgaard
Partner
Marius gets his kicks in life from developing stuff. Ideas. Technology. Products. Companies. International markets. So that is how he has spent his long career in Norwegian technology companies. Always developing something new. As the founder of The Life Science Cluster, he has an extensive network of relations in Norway’s bio-based industries. He thinks this will be pretty useful for the ShareLab community!
Phone: +47 92 84 66 21
Email: marius(a)sharelab.no
